Live
Promega BlogA Historic Milestone for PROTAC Research: What Vepdegestrant’s FDA Decision Means for Drug DiscoveryEndpoints NewsGSK goes to China for $1B siRNA deal in Arrowhead's obesity lanePharmaVoiceA new company rises from the ashes of Purdue PharmaCellDisrupted molecular glue complex drives RAS inhibitor resistanceCellBiodiversity and biogeography of the multi-kingdom cancer microbiomeLabiotechTop biotech deals in April 2026FierceBiotechGSK pens $1B deal with China’s SiranBio for oligonucleotide that could reduce abdominal fatThermo FisherThermo Fisher Scientific’s Clinical Research Business Named a Leader Among CROs in 2026 ISG Provider Lens™ Report for Use of AI in Clinical Trials - Yahoo FinanceFierceBiotechCellCentric raises $220M series D to advance myeloma drug through registration, eyes potential IPOFierceBiotechBayer buys Perfuse in $2.4B deal for midphase eye disease prospectEndpoints NewsCellCentric raises $220M to get multiple myeloma pill to marketFierceBiotechAfter a decade of hype, Najat Khan is bringing Recursion back down to earth

Archive

Latest Oldest
Total 10238
Page 314 / 569
Query --